Cellusion participated the mini seminar in ISSCR & JSRM 2021 Tokyo International Symposium "Stem Ce...
Dr. Hatou presented Cellusion business progress in the 2021 Cell & Gene Meeting on the Mesa.
Cellusion obtained 1st prize of Boehringer Ingelheim Innovation Prize 2021
Cellusion welcomes Stella and Toru as new board members
CLS001 Non-clinical Efficacy Study Result was published in Stem Cell Research.
CLS001 Clinical Study Plan Officially Approved by MHLW‘s Health Science Council
The Clinical Study Plan on Corneal Endothelial Cell Substitute from iPS Cells Transplant Plan for B...
Dr. Hatou presents recent research progress in 2021 ISSCR VIRTUAL conference.
Keio Univ.'s Corneal Endothelial Cell Substitute from iPS Cells Transplant Plan on Bullous Keratopa...
Cellusion introduced in The Nikkan Kogyo Shimbun.
Dr. Hatou ＆ Dr. Sayano presented recent research progress in the 20th Congress of the Japanese Soci...
Dr. Hatou introduced our business plan in RINK FESTIVAL 2021.
Dr. Hatou presented recent research progress in Japan Cornea Conference 2021.
Dr. Hatou presented Cellusion business progress in Genesis Digital 2020
Dr. Hatou presented recent research progress in 2020 ISSCR virtual conference.
Cellusion raises additional funding and welcomes a new board member
Cellusion moves HQ and opens a new laboratory in Nihombashi
Cellusion selected as J-TECH STARTUP 2019
Cellusion raises 360M JPY in series A funding
Cellusion selected as JHVS2019 Venture Award.
Cellusion Introduction Video Released
Cellusion has been selected Tokyo metropolitan government R&D facility support grant 2019.
Cellusion introduced in Co-founders site.
Cellusion introduced in KII investment stories.
Cellusion introduced in Nikkei article.
Dr. Hatou presented recent research progress in 2019 ISSCR annual conference.
Cellusion has been selected to NEDO STS program 2019